Literature DB >> 24621878

Resting heart rate and heart rate reserve in advanced heart failure have distinct pathophysiologic correlates and prognostic impact: a prospective pilot study.

Jan Benes1, Martin Kotrc1, Barry A Borlaug2, Katerina Lefflerova1, Petr Jarolim3, Bela Bendlova4, Antonin Jabor1, Josef Kautzner1, Vojtech Melenovsky5.   

Abstract

OBJECTIVES: The purpose of this study was to compare the prognostic impact of clinical and biomarker correlates of resting heart rate (HR) and chronotropic incompetence in heart failure (HF) patients.
BACKGROUND: The mechanisms and underlying pathophysiological influences of HR abnormalities in HF are incompletely understood.
METHODS: In a prospective pilot study, 81 patients with advanced systolic HF (97% were receiving beta-blockers) and 25 age-, sex-, and body-size matched healthy controls underwent maximal cardiopulmonary exercise testing with sampling of neurohormones and biomarkers.
RESULTS: Two-thirds of HF patients met criteria for chronotropic incompetence. Resting HR and HR reserve (HRR, a measure of chronotropic response) were not correlated with each other and were associated with distinct biomarker profiles. Resting HR correlated with increased myocardial stress (B-type natriuretic peptide [BNP]: r = 0.26; pro-A-type natriuretic peptide: r = 0.24; N-terminal-proBNP: r = 0.32) and inflammation (leukocyte count: r = 0.28; high-sensitivity C-reactive protein assay: r = 0.25). In contrast, HRR correlated with the neurohumoral response to HF (copeptin: r = -0.33; norepinephrine: r = -0.29) but not with myocyte stress or injury reflected by natriuretic peptides or hs-troponin I. Patients in the lowest chronotropic incompetence quartile (HRR ≤0.38) displayed more advanced HF, reduced exercise capacity, ventilatory inefficiency, and poorer quality of life. Over a median follow-up of 17 months, the combined endpoint of death or urgent transplant/assist device implantation occurred more frequently in patients with higher resting HR (>67 beats/min) or lower HRR, with both markers providing additive prognostic information.
CONCLUSIONS: Increased resting HR and chronotropic incompetence may reflect different pathophysiological processes, provide incremental prognostic information, and represent distinct therapeutic targets.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  biomarkers; chronotropic incompetence; exercise; heart failure; heart rate

Mesh:

Year:  2013        PMID: 24621878     DOI: 10.1016/j.jchf.2013.03.008

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  15 in total

Review 1.  Heart rate during exercise: mechanisms, behavior, and therapeutic and prognostic implications in heart failure patients with reduced ejection fraction.

Authors:  Stefania Paolillo; Piergiuseppe Agostoni; Fabiana De Martino; Francesca Ferrazzano; Fabio Marsico; Paola Gargiulo; Elisabetta Pirozzi; Caterina Marciano; Santo Dellegrottaglie; Pasquale Perrone Filardi
Journal:  Heart Fail Rev       Date:  2018-07       Impact factor: 4.214

Review 2.  Current Perspectives on Systemic Hypertension in Heart Failure with Preserved Ejection Fraction.

Authors:  Marty C Tam; Ran Lee; Thomas M Cascino; Matthew C Konerman; Scott L Hummel
Journal:  Curr Hypertens Rep       Date:  2017-02       Impact factor: 5.369

Review 3.  Rate adaptive pacing in people with chronic heart failure increases peak heart rate but not peak exercise capacity: a systematic review.

Authors:  H I Clark; M J Pearson; N A Smart
Journal:  Heart Fail Rev       Date:  2022-02-09       Impact factor: 4.214

4.  Heart failure in mice induces a dysfunction of the sinus node associated with reduced CaMKII signaling.

Authors:  Jian-Bin Xue; Almudena Val-Blasco; Moran Davoodi; Susana Gómez; Yael Yaniv; Jean-Pierre Benitah; Ana María Gómez
Journal:  J Gen Physiol       Date:  2022-04-22       Impact factor: 4.000

5.  Chronotropy: the Cinderella of heart failure pathophysiology and management.

Authors:  Peter H Brubaker; Dalane W Kitzman
Journal:  JACC Heart Fail       Date:  2013-06-03       Impact factor: 12.035

6.  Resting Heart Rate and Chronotropic Response to Exercise: Prognostic Implications in Heart Failure Across the Left Ventricular Ejection Fraction Spectrum.

Authors:  Mário Santos; Erin West; Hicham Skali; Daniel E Forman; Wilson Nadruz; Amil M Shah
Journal:  J Card Fail       Date:  2018-10-06       Impact factor: 5.712

7.  Acute Hemodynamic Index Predicts In-Hospital Mortality in Acute Decompensated Heart Failure.

Authors:  Renata R T Castro; Luka Lechnewski; Alan Homero; Denilson Campos de Albuquerque; Luis Eduardo Rohde; Dirceu Almeida; João David; Salvador Rassi; Fernando Bacal; Edimar Bocchi; Lidia Moura
Journal:  Arq Bras Cardiol       Date:  2021-01       Impact factor: 2.000

Review 8.  Relationships among norepinephrine levels, exercise capacity, and chronotropic responses in heart failure patients.

Authors:  Liza Grosman-Rimon; Evan Wright; Solomon Sabovich; Jordan Rimon; Sagi Gleitman; Doron Sudarsky; Alla Lubovich; Itzhak Gabizon; Spencer D Lalonde; Sharon Tsuk; Michael A McDonald; Vivek Rao; David Gutterman; Ulrich P Jorde; Shemy Carasso; Erez Kachel
Journal:  Heart Fail Rev       Date:  2022-03-24       Impact factor: 4.214

9.  Chronotropic incompetence can limit exercise tolerance in COPD patients with lung hyperinflation.

Authors:  Sébastien Hulo; Jocelyn Inamo; Aurélie Dehon; Olivier Le Rouzic; Jean-Louis Edme; Remi Neviere
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-10-17

10.  Non-linear Equation using Plasma Brain Natriuretic Peptide Levels to Predict Cardiovascular Outcomes in Patients with Heart Failure.

Authors:  Hiroki Fukuda; Hideaki Suwa; Atsushi Nakano; Mari Sakamoto; Miki Imazu; Takuya Hasegawa; Hiroyuki Takahama; Makoto Amaki; Hideaki Kanzaki; Toshihisa Anzai; Naoki Mochizuki; Akira Ishii; Hiroshi Asanuma; Masanori Asakura; Takashi Washio; Masafumi Kitakaze
Journal:  Sci Rep       Date:  2016-11-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.